Diabetes · 2017 · 21 citations · 31 references
Life SciencesEndocrinologyPhysiologyCell SignalingMetabolic RegulationSignal TransductionIon Channel PharmacologyIon Channel PhysiologyIon Channel RegulationIon Channel SignalingIon ChannelsSingle-channel ElectrophysiologyBeta Cell BiologyCa2+ SignalingGlucose ConcentrationGlucose-dependent Insulin SecretionGlucose-stimulated Insulin SecretionPancreatic Beta-cell FunctionPancreatic Beta-cell SecretionProtein Kinase G Signaling
Atrial natriuretic peptide (ANP) influences glucose homeostasis and possibly acts as a link between the cardiovascular system and metabolism, especially in metabolic disorders like diabetes. The current study evaluated effects of ANP on β-cell function by the use of a β-cell–specific knockout of the ANP receptor with guanylate cyclase activity (βGC-A-KO). ANP augmented insulin secretion at the threshold glucose concentration of 6 mmol/L and decreased KATP single-channel activity in β-cells of control mice but not of βGC-A-KO mice. In wild-type β-cells but not β-cells lacking functional KATP channels (SUR1-KO), ANP increased electrical activity, suggesting no involvement of other ion channels. At 6 mmol/L glucose, ANP readily elicited Ca2+ influx in control β-cells. This effect was blunted in β-cells of βGC-A-KO mice, and the maximal cytosolic Ca2+ concentration was lower. Experiments with inhibitors of protein kinase G (PKG), protein kinase A (PKA), phosphodiesterase 3B (PDE3B), and a membrane-permeable cyclic guanosine monophosphate (cGMP) analog on KATP channel activity and insulin secretion point to participation of the cGMP/PKG and cAMP/PKA/Epac (exchange protein directly activated by cAMP) directly activated by cAMP Epac pathways in the effects of ANP on β-cell function; the latter seems to prevail. Moreover, ANP potentiated the effect of glucagon-like peptide 1 (GLP-1) on glucose-induced insulin secretion, which could be caused by a cGMP-mediated inhibition of PDE3B, which in turn reduces cAMP degradation.
31
Impact of Obesity on Plasma Natriuretic Peptide Levels
Thomas J. Wang, Martin G. Larson, Daniel Levy et al. · Circulation · 2004 · 1K citations · Full text
Medicine, Cardiology, Physiology +15
Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides
Sandeep R. Das, Mark H. Drazner, Daniel L. Dries et al. · Circulation · 2005 · 430 citations
Medicine, Cardiology, Physiology +13